PTK2 and breast carcinoma: In breast cancer cells, glucose metabolism is promoted by β1-integrin signaling through Twist, a regulator of epithelial-mesenchymal transition (EMT) (Yang et al., 2016), while knockdown of Glut1 in breast cancer cells lowers integrin β1 levels followed by reduced Src and FAK expression (Oh et al., 2017).